A patient with prostate cancer is about to start androgen deprivation therapy. Where do you find the cardiovascular guidance—and how do you turn that guidance into a practical risk assessment? That’s the journey I demonstrate in this video. I built the Cardio-Oncology Living Guideline to make evidence easier to find and use across cancer types and treatments, with a dedicated cardiovascular risk tool for prostate cancer. Explore it here: cardonc-guideline.com In the walkthrough, I show how to: • Find what has changed: review evidence published since the 2022 ESC cardio-oncology guidelines - academic.oup.com/eurheartj/a… and see proposed recommendation updates. • Navigate to the clinical question: search for a treatment or topic, open the relevant section, and follow the references to the original evidence. • Assess cardiovascular risk in prostate cancer: start with rapid triage, then add optional Guha–Stabellini scores and AHA PREVENT base-model estimates when the necessary information is available. • Generate a report: bring the assessment together for clinician review and support clinical documentation. The rapid triage pathway can be used without entering laboratory values. Numeric assessment sits in a separate tab, so clinicians can choose the level of detail appropriate to the encounter. AI (OpenAI ASTRA models) helps gather and organize evidence. I personally review every proposed update against the original sources before publication. Human review and editorial accountability are central to this project. This is an independent educational resource. The website clearly distinguishes proposed recommendation changes from formally adopted ESC guidance. For our cardio-oncology community, including colleagues in the @ICOSociety, I hope this helps connect evidence reading with structuring an assessment in clinic. Watch the demonstration, explore the guideline, and try the calculator. What would make this more useful in your practice? Feedback on navigation, clinical content, and the calculator will help shape the next updates. #CardioOncology #MedicalEducation @mcg_urology @md_addison @CardioOncology @OncoAlert @OncBrothers @datsunian @DrGuptaD @daehyunleemd @DrBonnieKy @DrTochiOkwuosa @drbrowncares @MCG_AUG @ACCinTouch @escardio @MCGCardFellows @ASCOPost @neerajaiims @DrChoueiri @PCFnews @montypal @PGrivasMDPhD

RADICAL PC-2 gives the strongest randomized evidence yet for organizing #CardioOncology around #ProstateCancer: assess CV risk in everyone—but don’t refer every man starting ADT to a specialist. New at #ESC2026. 🧵 @JAMAInternalMed @JACCJournals @escardio #ESCCongress @DarrylLeong @pinthusj